Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 531 active Multiple Myeloma trials
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Study Type: Interventional Phase 1
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
Study Type: Interventional Phase 1
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Study Type: Interventional Phase 1
A Rollover Study of CC-122
Study Type: Interventional Phase 1
Dietary Reporting In The Amyloidoses
Study Type: Interventional
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Study Type: Interventional Phase 2
Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Study Type: Observational
Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors
Study Type: Interventional Phase 1
There are 531 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now